Sometimes in the course of putting together the daily linkfests and standalone posts I end up with too many items in a particular area. (Here’s one from a few weeks ago.) With everything else going on I ended up with a number of coronavirus-related items. The news was correctly focused on the protests, but the coronavirus is still out there making people sick. Please be careful and stay safe.

The disease

What if Covid-19 isn’t a respiratory disease? The range of symptoms look more like a vascular disease. (Medium)

How heart drugs are being used to treat Covid-19 patients. (WSJ)


The American public wants a rational reopening of the economy. (Barry Ritholtz)

Why the argument about Covid-19 fatality rates doesn’t matter – it’s deadly enough. (Scientific American)

Serious questions are being asked about the data from an obscure company that was used in high profile coronavirus papers. (The Guardian)

Why we need to distinguish between the effects of the virus itself and the government’s reaction to it. (FT Alphaville)

What lessons can be drawn from the OC43 pandemic of 1889-90? (The Spectator)


Some Covid-19 patients are seeing symptoms months after infection. (The Atlantic)

Why do some Covid-19 patients keep relapsing? (Vox)

Some recovered Covid-19 patients have not yet recovered their sense of smell and/or taste. (WSJ)


Front line medical workers should use N95 masks not surgical masks. (NYTimes)

How to wear and use a face mask in pandemic. (Scientific American)

The WHO now recommends universal mask-wearing in public where social distancing cannot occur.  (Vox)


Prophylactic hydroxychloroquine doesn’t help prevent the onset of Covid-19. (STAT)

There is some evidence that Vitamin D deficient patients are more at-risk of Covid-19. (The Atlantic)

How antibody injections could help fight Covid-19. (The Conversation)


The distribution of Remdesivir supplies has improved but still isn’t perfect. (WSJ)

Doctors aggressively prescribed antibiotics early in the pandemic. (NYTimes)

Staying safe

How to stay safe as parks reopen. (Outside)

Going back to the office? Some things to consider. (WSJ)

Movie theaters may present less risk of infection than previously thought. (Quartz)

Researchers are studying the link between the coronavirus and high altitudes. (Washington Post)

The potential costs of protesting in the midst of a pandemic are notably higher. (Interfluidity)

Earlier on Abnormal Returns

Coronavirus links: testing and safety. (Abnormal Returns)

Acceptable risks in a world full of uncertainty. (Abnormal Returns)

Having no plan is just as bad as not following the plan you have. (Abnormal Returns)

This content, which contains security-related opinions and/or information, is provided for informational purposes only and should not be relied upon in any manner as professional advice, or an endorsement of any practices, products or services. There can be no guarantees or assurances that the views expressed here will be applicable for any particular facts or circumstances, and should not be relied upon in any manner. You should consult your own advisers as to legal, business, tax, and other related matters concerning any investment.

The commentary in this “post” (including any related blog, podcasts, videos, and social media) reflects the personal opinions, viewpoints, and analyses of the Ritholtz Wealth Management employees providing such comments, and should not be regarded the views of Ritholtz Wealth Management LLC. or its respective affiliates or as a description of advisory services provided by Ritholtz Wealth Management or performance returns of any Ritholtz Wealth Management Investments client.

References to any securities or digital assets, or performance data, are for illustrative purposes only and do not constitute an investment recommendation or offer to provide investment advisory services. Charts and graphs provided within are for informational purposes solely and should not be relied upon when making any investment decision. Past performance is not indicative of future results. The content speaks only as of the date indicated. Any projections, estimates, forecasts, targets, prospects, and/or opinions expressed in these materials are subject to change without notice and may differ or be contrary to opinions expressed by others.

Please see disclosures here.

Please see the Terms & Conditions page for a full disclaimer.